Today Caryl Barnard recruited the
1234th and final MaGiCAD patient. The first patient was recruited
on 28/11/01. We are excited to be commencing the next phase of the
study, but also somewhat sad that we will no longer be meeting interesting
with helpful hospital staff who have
all been so
with their time. Many thanks to everyone
who has contributed to the success of MaGiCAD over the last 4 years.
||Today the 100th (and final) MaGiCAD partner was recruited
into the study by Caryl Barnard. The first partner was recruited on
|| It is with regret we announce that Claire Nugent
has recently decided not to return to MaGiCAD. She
been on maternity leave since the birth of her daughter last year.
Claire started work as a clinical research assistant in October 2002
and took on the roll of Study Co-ordinator when Sarah
maternity leave. We
in MaGiCAD and will miss her.
||A paper we submitted to
the journal Atherosclerosis was recently accepted for publication.
This will be the first paper published using samples from the MaGiCAD
study. Click here for
Today was Sarah Hayns's last day
with the MaGiCAD team. Sarah was the first clinical research assistant
to begin work on the
MaGiCAD study, in October 2001, and many of the procedures that we
use today were set up by her. Sarah went on maternity leave in October
'02 and returned part-time in July of 2003. She resumed her
role as Study Co-ordinator when Claire Nugent left on maternity leave
in April. Sarah has gone to a permanent position based at Addenbrooke's
Hospital in Cambridge. We all wish her well in her new job. Sarah
was an energetic, conscientious and efficient member of the MaGiCAD
and will be missed by us all.
||Last week Ruth Westbrooke joined us for the Summer period
to do some analysis of the MaGiCAD samples. She is a
student in her second year studying Natural Sciences at Cambridge
||Today Caryl Barnard recruited our 1000th MaGiCAD study
recruit! Please click
here for more information.
||Congratulations to Claire and husband David on the arrival
of Amélie, born 14 June. All are doing well.
||On 18 April Claire Nugent left to go on to maternity
leave. We all send her our best wishes for June.
||No news for a while, but we have now recruited 888 patients
||We are now well over 700 patients recruited into MaGiCAD. Thank
you all for your help! And have a very happy Christmas!
||First MaGiCAD partner recruited into study by Caryl Barnard.
new Clinical Research Assistant, Annik Panicker started today. See
the Staff page for more details.
||The 500th patient was recruited into MaGiCAD today!
||We are currently recruiting another full-time CRA whose
job description includes some time working on the MaGiCAD study. NB:
Applications have now closed.
||Claire and Caryl are today recruiting our 400th patient
into MaGiCAD. This is a big milestone, as the original study design
catered for only 400 patients.
||MaGiCAD is now up to 350 patients! Only another 1300
||There has been substantial media interest in the new
metabonomic test for heart disease. The BBC has the story on
its web-site, while there has been substantial coverage in many National
and local newspapers (including The
Telegraph, and The
|On the 24 November we published in the journal Nature
Medicine a paper describing the use of metabonomics as a potential
alternative to angiography for diagnosing heart disease. This is
potentially a very significant step forward in replacing angiography
with a minimially-invasive alternative. One of the aims of MaGiCAD
is to further evaluate the use of metabonomics for diagnosing heart
disease. Follow this
link to the paper. The joint press release from Imperial College,
London, the University of Cambridge and Papworth Hospital is here.
has left us on her maternity leave. We wish her and her new arrival
(due late November) the very best wishes.
We have now employed two further Clinical Research Assistants, Caryl
Barnard and Claire Nugent. See the Staff page
for more details.
We will shortly be interviewing for another clinical research assistant
to be based at Papworth Hospital. This should increase the rate at
which MaGiCAD will grow!
Initial analysis has now been completed. See Results for
MaGiCAD has now been computerised! All new
questionnaires are now being administered using an Apple
iBook computer. This will mean that time will not need to be
spent transferring data from paper onto computer databases in the